Manufacturing Subcommittee of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology (formerly called Advisory Committee for Pharmaceutical Science); Notice of Meeting; Cancellation, 16797 [E7-6288]
Download as PDF
16797
Federal Register / Vol. 72, No. 65 / Thursday, April 5, 2007 / Notices
ANNUAL BURDEN ESTIMATES—Continued
Number of
respondents
Instrument
Program/Project Management (SF–PPR–F) .................................................
Estimated Total Annual Burden
Hours: 11,688.
In compliance with the requirements
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. E-mail address:
infocollection@acf.hhs.gov. All requests
should be identified by the title of the
information collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
consideration will be given to comments
and suggestions submitted within 60
days of this publication.
Dated: April 2, 2007.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 07–1676 Filed 4–4–07; 8:45 am]
Number of
responses per
respondent
37
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Advisory Committee for
Pharmaceutical Science and Clinical
Pharmacology (formerly called
Advisory Committee for
Pharmaceutical Science); Notice of
Meeting; Cancellation
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The meeting of the Advisory
Committee for Pharmaceutical Science
and Clinical Pharmacology scheduled
for May 1 and 2, 2007, is cancelled. This
meeting was announced in the Federal
Register of March 16, 2007 (72 FR
12621).
FOR FURTHER INFORMATION CONTACT:
Victoria Ferretti-Aceto, Center for Drug
Evaluation and Research (HFD–21),
Food and Drug Administration, 5600
Fishers Lane (for express delivery, 5630
Fishers Lane, rm. 1093), Rockville, MD
20857, 301–827–7001, FAX: 301–827–
6776, e-mail:
Victoria.ferrettiaceto@fda.hhs.gov, or
FDA Advisory Committee Information
Line, 1–800–741–8138 (301–443–0572
in the Washington, DC area), code
3014512539. Please call the Information
Line for up-to-date information on this
meeting.
Dated: March 29, 2007.
Randall W. Lutter,
Associate Commissioner for Policy and
Planning.
[FR Doc. E7–6283 Filed 4–4–07; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4184–01–M
jlentini on PROD1PC65 with NOTICES
Food and Drug Administration
Manufacturing Subcommittee of the
Advisory Committee for
Pharmaceutical Science and Clinical
Pharmacology (formerly called
Advisory Committee for
Pharmaceutical Science); Notice of
Meeting; Cancellation
AGENCY:
Food and Drug Administration,
HHS.
VerDate Aug<31>2005
19:11 Apr 04, 2007
Jkt 211001
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Average
burden hours
per response
1
ACTION:
Total burden
hours
.50
19
Notice.
SUMMARY: The meeting of the
Manufacturing Subcommittee of the
Advisory Committee for Pharmaceutical
Science and Clinical Pharmacology
scheduled for April 30, 2007, is
cancelled. This meeting was announced
in the Federal Register of March 5, 2007
(72 FR 9767).
FOR FURTHER INFORMATION CONTACT:
Victoria Ferretti-Aceto, Center for Drug
Evaluation and Research (HFD–21),
Food and Drug Administration, 5600
Fishers Lane (for express delivery, 5630
Fishers Lane, rm. 1093), Rockville, MD
20857, 301–827–7001, FAX: 301–827–
6776, e-mail:
victoria.ferrettiaceto@fda.hhs.gov, or
FDA Advisory Committee Information
Line, 1–800–741–8138 (301–443–0572
in the Washington, DC area), code
3014512539. Please call the Information
Line for up-to-date information on this
meeting.
Dated: March 29, 2007.
Randall W. Lutter,
Associate Commissioner for Policy and
Planning.
[FR Doc. E7–6288 Filed 4–4–07; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Notice of Meeting of the Advisory
Committee on Organ Transplantation
Health Resources and Services
Administration, HHS.
AGENCY:
SUMMARY: Pursuant to Public Law 92–
463, the Federal Advisory Committee
Act, as amended (5 U.S.C. Appendix 2),
notice is hereby given of the twelfth
meeting of the Advisory Committee on
Organ Transplantation (ACOT),
Department of Health and Human
Services (HHS). The meeting will be
held from approximately 9 a.m. to 5:30
p.m. on May 15, 2007, and from 9 a.m.
to 3 p.m. on May 16, 2007, at the
DoubleTree Hotel & Executive Meeting
Center, 1750 Rockville Pike, Rockville,
MD 20852. The meeting will be open to
the public; however, seating is limited
E:\FR\FM\05APN1.SGM
05APN1
Agencies
[Federal Register Volume 72, Number 65 (Thursday, April 5, 2007)]
[Notices]
[Page 16797]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-6288]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Manufacturing Subcommittee of the Advisory Committee for
Pharmaceutical Science and Clinical Pharmacology (formerly called
Advisory Committee for Pharmaceutical Science); Notice of Meeting;
Cancellation
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The meeting of the Manufacturing Subcommittee of the Advisory
Committee for Pharmaceutical Science and Clinical Pharmacology
scheduled for April 30, 2007, is cancelled. This meeting was announced
in the Federal Register of March 5, 2007 (72 FR 9767).
FOR FURTHER INFORMATION CONTACT: Victoria Ferretti-Aceto, Center for
Drug Evaluation and Research (HFD-21), Food and Drug Administration,
5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093),
Rockville, MD 20857, 301-827-7001, FAX: 301-827-6776, e-mail:
victoria.ferrettiaceto@fda.hhs.gov, or FDA Advisory Committee
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC
area), code 3014512539. Please call the Information Line for up-to-date
information on this meeting.
Dated: March 29, 2007.
Randall W. Lutter,
Associate Commissioner for Policy and Planning.
[FR Doc. E7-6288 Filed 4-4-07; 8:45 am]
BILLING CODE 4160-01-S